title: [Epigenetic therapy in myelodysplastic syndromes (MDS). Treatment with DNA methyltransferase inhibitors].
authors.affiliation: Universitätsklinikum Freiburg, Hämatologie und Onkologie, Abt. Innere Medizin I, Hugstetter Str. 55, D-79106 Freiburg.
authors.forename: Michael
authors.initials: M
authors.lastname: Daskalakis
authors.forename: Nadja
authors.initials: N
authors.lastname: Blagitko-Dorfs
authors.forename: Björn
authors.initials: B
authors.lastname: Hackanson
authors.forename: Michael
authors.initials: M
authors.lastname: Lübbert
mesh_terms: D001374:Azacitidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019175:DNA Methylation / Q000187:drug effects; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors*; D000077209:Decitabine; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D044127:Epigenesis, Genetic; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D004791:Enzyme Inhibitors; D000077209:Decitabine; D015254:DNA Modification Methylases; D001374:Azacitidine